Literature DB >> 16369903

Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.

Fettah Fevzi Ersoy1, Stauros Ploumis Passadakis, Paul Tam, Evaggelos Dimitros Memmos, Pericles Konstantinos Katopodis, Cetin Ozener, Fehmi Akçiçek, Taner Camsari, Kenan Ateş, Rezzan Ataman, John George Vlachojannis, Athanasios Nicholas Dombros, Cengiz Utaş, Tekin Akpolat, Semra Bozfakioğlu, George Wu, Ibrahim Karayaylali, Turgay Arinsoy, Panagiotis Charalampos Stathakis, Mahmut Yavuz, John Dimitrios Tsakiris, Chrysostomos Athanasios Dimitriades, Mehmet Emin Yilmaz, Meral Gültekin, Binnur Karayalçin, Mehmet Yardimsever, Dimitrios George Oreopoulos.   

Abstract

The aim of this study was to assess the clinical and laboratory correlations of bone mineral density (BMD) measurements among a large population of patients on chronic peritoneal dialysis (PD). This cross-sectional, multicenter study was carried out in 292 PD patients with a mean age of 56 +/- 16 years and mean duration of PD 3.1 +/- 2.1 years. Altogether, 129 female and 163 male patients from 24 centers in Canada, Greece, and Turkey were included in the study. BMD findings, obtained by dual-energy X-ray absorptiometry (DEXA) and some other major clinical and laboratory indices of bone mineral deposition as well as uremic osteodystrophy were investigated. In the 292 patients included in the study, the mean lumbar spine T-score was -1.04 +/- 1.68, the lumbar spine Z-score was -0.31 +/- 1.68, the femoral neck T-score was -1.38 +/- 1.39, and the femoral neck Z score was -0.66 +/- 1.23. According to the WHO criteria based on lumbar spine T-scores, 19.2% of 292 patients were osteoporotic, 36.3% had osteopenia, and 44.4% had lumbar spine T-scores within the normal range. In the femoral neck area, the prevalence of osteoporosis was slightly higher (26%). The prevalence of osteoporosis was 23.3% in female patients and 16.6% in male patients with no statistically significant difference between the sexes. Agreements of lumbar spine and femoral neck T-scores for the diagnosis of osteoporosis were 66.7% and 27.3% and 83.3% for osteopenia and normal BMD values, respectively. Among the clinical and laboratory parameters we investigated in this study, the body mass index (BMI) (P < 0.001), daily urine output, and urea clearance time x dialysis time/volume (Kt/V) (P < 0.05) were statistically significantly positive and Ca x PO(4) had a negative correlation (P < 0.05) with the lumbar spine T scores. Femoral neck T scores were also positively correlated with BMI, daily urine output, and KT/V; and they were negatively correlated with age. Intact parathyroid hormone levels did not correlate with any of the BMD parameters. Femoral neck Z scores were correlated with BMI (P < 0.001), and ionized calcium (P < 0.05) positively and negatively with age, total alkaline phosphatase (P < 0.05), and Ca x P (P < 0.01). The overall prevalence of fractures since the initiation of PD was 10%. Our results indicated that, considering their DEXA-based BMD values, 55% of chronic PD patients have subnormal bone mass-19% within the osteoporotic range and 36% within the osteopenic range. Our findings also indicate that low body weight is the most important risk factor for osteoporosis in chronic PD patients. An insufficient dialysis dose (expressed as KT/V) and older age may also be important risk factors for osteoporosis of PD patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16369903     DOI: 10.1007/s00774-005-0650-3

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  26 in total

1.  Effect of low-calcium hemodialysate on bone metabolism.

Authors:  T Saisu; Y Wakabayashi; K Yamada; T Shigematsu; S Goto; M Nishimura; Y Miura; H Nakano; H Moriya
Journal:  J Bone Miner Metab       Date:  2000       Impact factor: 2.626

2.  Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone.

Authors:  M Coco; H Rush
Journal:  Am J Kidney Dis       Date:  2000-12       Impact factor: 8.860

3.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

Review 4.  Osteoporosis in chronic kidney disease.

Authors:  John Cunningham; Stuart M Sprague; Jorge Cannata-Andia; Maria Coco; Martine Cohen-Solal; Lorraine Fitzpatrick; David Goltzmann; Marie-Helene Lafage-Proust; Mary Leonard; Susan Ott; Mariano Rodriguez; Catherine Stehman-Breen; Paula Stern; Jose Weisinger
Journal:  Am J Kidney Dis       Date:  2004-03       Impact factor: 8.860

5.  Racial differences in bone mineral density and bone loss among end-stage renal disease patients.

Authors:  C O Stehman-Breen; D Sherrard; A Walker; R Sadler; A Alem; J Lindberg
Journal:  Am J Kidney Dis       Date:  1999-05       Impact factor: 8.860

6.  Risk factors for hip fracture among patients with end-stage renal disease.

Authors:  C O Stehman-Breen; D J Sherrard; A M Alem; D L Gillen; S R Heckbert; C S Wong; A Ball; N S Weiss
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

7.  A comparison of quantitative computed tomography and dual X-ray absorptiometry for evaluation of bone mineral density in patients on chronic hemodialysis.

Authors:  U Barnas; A Schmidt; G Seidl; A Kaider; P Pietschmann; G Mayer
Journal:  Am J Kidney Dis       Date:  2001-06       Impact factor: 8.860

8.  Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.

Authors:  Pablo Ureña; Oana Bernard-Poenaru; Agnès Ostertag; Claude Baudoin; Martine Cohen-Solal; Tom Cantor; Marie Christine de Vernejoul
Journal:  Nephrol Dial Transplant       Date:  2003-11       Impact factor: 5.992

Review 9.  Pain in hemodialysis patients: prevalence, cause, severity, and management.

Authors:  Sara N Davison
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

10.  Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease.

Authors:  A J Hutchison; R W Whitehouse; H F Boulton; J E Adams; E B Mawer; T J Freemont; R Gokal
Journal:  Kidney Int       Date:  1993-11       Impact factor: 10.612

View more
  21 in total

1.  Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis.

Authors:  A-J Chang; Q Ying; X-N Chen; W-M Wang; N Chen
Journal:  Osteoporos Int       Date:  2016-07-08       Impact factor: 4.507

2.  Bone mineral density and parathyroid function in patients on maintenance hemodialysis.

Authors:  Cs Ambrus; Cs Almasi; K Berta; Gy Deak; A Marton; M Zs Molnar; Zs Nemeth; Cs Horvath; P Lakatos; M Szathmari; I Mucsi
Journal:  Int Urol Nephrol       Date:  2010-01-21       Impact factor: 2.370

3.  Bone microarchitecture in hemodialysis patients assessed by HR-pQCT.

Authors:  Daniel Cejka; Janina M Patsch; Michael Weber; Danielle Diarra; Markus Riegersperger; Zeljko Kikic; Christian Krestan; Claudia Schueller-Weidekamm; Franz Kainberger; Martin Haas
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

4.  FGF-23, α-Klotho Gene Polymorphism and Their Relationship with the Markers of Bone Metabolism in Chronic Peritoneal Dialysis Patients.

Authors:  Vural Taner Yilmaz; Sebahat Ozdem; Levent Donmez; Ramazan Cetinkaya; Gultekin Suleymanlar; F Fevzi Ersoy
Journal:  Eurasian J Med       Date:  2015-06

5.  Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease.

Authors:  S A Jamal; A M Cheung; S L West; C E Lok
Journal:  Osteoporos Int       Date:  2012-12       Impact factor: 4.507

6.  The association of serum ionized calcium and vitamin D with adult cognitive performance.

Authors:  Anna-Maija Tolppanen; Dylan M Williams; Debbie A Lawlor
Journal:  Epidemiology       Date:  2011-01       Impact factor: 4.822

Review 7.  Fracture risk assessment in patients with chronic kidney disease.

Authors:  S A Jamal; S L West; P D Miller
Journal:  Osteoporos Int       Date:  2011-09-08       Impact factor: 4.507

8.  Increased risk of cardiovascular events in end-stage renal disease patients with osteoporosis: a nationwide population-based cohort study.

Authors:  T-M Yu; C-L Lin; K-H Shu; Y-L Liu; C-H Chen; S-T Huang; C-H Kao
Journal:  Osteoporos Int       Date:  2014-12-10       Impact factor: 4.507

9.  Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease.

Authors:  Csaba P Kovesdy; Olga Kuchmak; Jun L Lu; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

10.  Factors associated with low bone mass in the hemodialysis patients--a cross-sectional correlation study.

Authors:  Guey-Shiun Huang; Tzong-Shinn Chu; Meei-Fang Lou; Shiow-Li Hwang; Rong-Sen Yang
Journal:  BMC Musculoskelet Disord       Date:  2009-06-04       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.